Angiotensin-II administration is useful for the detection of liver metastasis from pancreatic cancer during pharmacoangiographic computed tomography

Figure 1 A 78 years old woman with liver metastasis from pancreatic cancer. A:Conventional angiographic CT; B: Pharmacoangiographic CT with angiotensin II. The tumor to liver contrast is increased, and well demarcated low density area in the liver is now highly indicative of liver metastasis.

Figure 2 Comparison of the attenuation value of the enhanced liver metastasis in angiographic CT with and without angiotensin II (AT-II).

Figure 3 Tumor to liver parenchyma contrast in angiographic CT with and without angiotensin II (AT-II) in 35 patients with liver metastasis due to pancreatic cancer.